Algert Global LLC Amneal Pharmaceuticals, Inc. Transaction History

Algert Global LLC

$4.77 Billion
Q2 2025

A detailed history of Algert Global LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Algert Global LLC holds 1,041,064 shares of AMRX stock, worth $10.7 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

1,041,064

Previous 560,783 85.64%

Holding current value

$10.7 Million

Previous $4.7 Million 79.23%

% of portfolio

0.18%

Previous 0.12%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$6.97 - $8.23 $3.35 Million - $3.95 Million	480,281 Added 85.64%	1,041,064 $8.42 Million
Q1 2025 May 13, 2025	BUY	$7.72 - $9.01 $886,163 - $1.03 Million	114,788 Added 25.74%	560,783 $4.7 Million
Q4 2024 Feb 14, 2025	SELL	$7.69 - $9.25 $17,002 - $20,451	-2,211 Reduced 0.49%	445,995 $3.53 Million
Q3 2024 Nov 12, 2024	SELL	$6.42 - $8.83 $29,005 - $39,893	-4,518 Reduced 1.0%	448,206 $3.73 Million
Q2 2024 Aug 14, 2024	BUY	$5.36 - $7.11 $249,438 - $330,878	46,537 Added 11.46%	452,724 $2.88 Million
Q1 2024 May 14, 2024	BUY	$5.24 - $6.34 $522,097 - $631,698	99,637 Added 32.5%	406,187 $2.46 Million
Q4 2023 Feb 14, 2024	BUY	$3.36 - $6.21 $211,512 - $390,919	62,950 Added 25.84%	306,550 $1.86 Million
Q3 2023 Nov 13, 2023	BUY	$2.76 - $4.59 $149,150 - $248,043	54,040 Added 28.51%	243,600 $1.03 Million
Q2 2023 Aug 14, 2023	SELL	$1.33 - $3.1 $102,731 - $239,450	-77,242 Reduced 28.95%	189,560 $588,000
Q1 2023 May 12, 2023	SELL	$1.27 - $2.7 $80,843 - $171,871	-63,656 Reduced 19.26%	266,802 $371,000
Q4 2022 Feb 13, 2023	BUY	$1.96 - $2.61 $216,756 - $288,639	110,590 Added 50.3%	330,458 $658,000
Q3 2022 Nov 15, 2022	SELL	$2.02 - $3.62 $34,931 - $62,600	-17,293 Reduced 7.29%	219,868 $444,000
Q2 2022 Aug 15, 2022	SELL	$3.01 - $4.46 $165,242 - $244,845	-54,898 Reduced 18.8%	237,161 $754,000
Q1 2022 May 16, 2022	BUY	$3.9 - $4.89 $744,377 - $933,334	190,866 Added 188.62%	292,059 $1.22 Million
Q4 2021 Feb 14, 2022	SELL	$3.95 - $5.85 $346,983 - $513,887	-87,844 Reduced 46.47%	101,193 $485,000
Q3 2021 Nov 15, 2021	BUY	$4.31 - $5.64 $371,422 - $486,038	86,177 Added 83.78%	189,037 $1.01 Million
Q2 2021 Aug 13, 2021	BUY	$5.12 - $6.82 $286,054 - $381,033	55,870 Added 118.9%	102,860 $527,000
Q1 2021 May 14, 2021	BUY	$4.74 - $7.38 $222,732 - $346,786	46,990 New	46,990 $316,000
Q1 2020 May 13, 2020	SELL	$2.46 - $5.35 $317,389 - $690,257	-129,020 Closed	0 $0
Q4 2019 Feb 18, 2020	BUY	$2.65 - $5.56 $171,269 - $359,342	64,630 Added 100.37%	129,020 $622,000
Q3 2019 Nov 14, 2019	BUY	$2.29 - $7.1 $147,453 - $457,169	64,390 New	64,390 $187,000

Others Institutions Holding AMRX

# of Institutions

252

Shares Held

146M

Call Options Held

194K

Put Options Held

49.3K

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.55B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Account

Algert Global LLC Amneal Pharmaceuticals, Inc. Transaction History